Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25013589 | 0.95 | BTN3A1 (0.31) | BTN3A1 | |
| SCHEMBL25012629 | 0.88 | CYP3A4 (0.33) | BTN3A1 | |
| SCHEMBL24148988 | 0.87 | TMPRSS2 (0.39) | BTN3A1 | |
| SCHEMBL25012545 | 0.86 | BTN3A1 (0.33) | BTN3A1 | |
| SCHEMBL24148946 | 0.85 | CYP3A4 (0.32) | BTN3A1 | |
| SCHEMBL30491112 | 0.84 | CYP3A4 (0.31) | BTN3A1 | |
| SCHEMBL10154106 | 0.83 | CYP3A4 (0.34) | BTN3A1 | |
| SCHEMBL30269868 | 0.83 | TMPRSS2 (0.31) | — | |
| SCHEMBL25012888 | 0.82 | CYP3A4 (0.35) | BTN3A1 | |
| SCHEMBL21283650 | 0.82 | CYP3A4 (0.33) | BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040586-A1 | 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | GILEAD SCIENCES, INC. | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230040586-A1 | 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | TYMP, PNP, DUT | BTN3A1 3427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.